Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Statins and Neuroprotection: Basic Pharmacology Needed.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway.
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome.
Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.
Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
[Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors.
Value, challenges, and satisfaction of certification for multiple sclerosis specialists.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer's Disease, and Multiple Sclerosis.
Rituximab combination therapy in relapsing multiple sclerosis.
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Pages
« first
‹ previous
…
369
370
371
372
373
374
375
376
377
…
next ›
last »